More NewsRead More
Acura Pharmaceuticals Initiates Clinical Study of Meth-Resistant Nexafed(R) Extended-Release Formulations
February 16, 2015
Acura Pharmaceuticals Expands Meth-Resistant Decongestant Line With NEXAFED(R) Sinus Pressure + Pain
February 05, 2015
Direction of Market Influences: New Coverage of Acorda, Acura Pharmaceuticals, Adamas, Adamis and Addus HomeCare
January 14, 2015
from PR Newswire
Acura Pharmaceuticals Partners With Egalet Corporation to Commercialize Immediate Release Oxycodone Product Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
January 08, 2015
Acura Pharmaceuticals Receives Additional U.S. Patent for Abuse Deterrent Drug Formulations
December 08, 2014
Acura Pharmaceuticals Announces Third Quarter 2014 Financial Results
November 03, 2014
Acura Pharmaceuticals to Host Third Quarter 2014 Financial Results Conference Call on November 4, 2014
October 28, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here